This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (178)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Knud Kragballe, MD, PhD

Arch Dermatol. 1989;125(12):1647-1652.

Abstract
• Calcipotriol (the synthetic compound MC 903) is a structural analogue of naturally occurring, biologically active calcitriol. Calcipotriol and calcitriol (1,25-dihydroxy vitamin D3) show similar receptor binding and comparable effects on cell differentiation. However, calcipotriol seems to be at least 100 times less potent in its effects on calcium metabolism. In a double-masked study involving 50 patients with psoriasis vulgaris, the efficacy and tolerability of ointments containing various calcipotriol concentrations (25,50, or 100 µg/g) or the vehicle alone were compared in a study involving a right-left, within-patient randomized design. Patients were treated twice daily for 8 weeks. Marked improvement was seen in 40% of the patients treated with the 25-µg/g concentration of calcipotriol in 63% of patients treated with the 50-µg/g concentration, and in 88% treated with the 100-µg/g concentration. No patient treated with placebo had more than slight improvement. Five patients developed facial dermatitis during the study. The serum levels of ionized calcium were unchanged. This study demonstrates that calcipotriol ointment provides an effective and well-tolerated treatment of psoriasis vulgaris.

(Arch Dermatol. 1989;125:1647-1652)

Author Affiliations
From the Department of Dermatology, Marselisborg Hospital, University of Aarhus (Denmark).

Footnotes
Accepted for publication March 27, 1989.

Reprint requests to Department of Dermatology, Marselisborg Hospital, DK-8000 Aarhus C, Denmark.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor
Cordero et al.
J. Biol. Chem. 2002;277:38965-38971.
ABSTRACT | FULL TEXT  

What Is the Role of Topical Calcipotriol in the Treatment of Mild to Moderate Chronic Plaque Psoriasis?
Popescu and Popescu
Arch Dermatol 2000;136:1547-1549.
FULL TEXT  

Comparison of Calcipotriene (Dovonex) With a Coal Tar Emulsion (Exorex) in Treating Psoriasis in Adults: A Pilot Study
Veronikis et al.
Arch Dermatol 1999;135:474-475.
FULL TEXT  

A 61-Year-Old Man With Psoriasis
Baughman
JAMA 1996;276:1421-1428.
ABSTRACT  

Photosensitivity Associated With Combined UV-B and Calcipotriene Therapy
McKenna and Stern
Arch Dermatol 1995;131:1305-1307.
ABSTRACT  

The Evolution of Vitamin D Analogues for the Treatment of Psoriasis
Lebwohl
Arch Dermatol 1995;131:1323-1324.
ABSTRACT  

Treatment of Psoriasis
Greaves and Weinstein
NEJM 1995;332:581-589.
FULL TEXT  

Calcipotriene Ointment: A New Topical Treatment for Psoriasis
Journal Watch Dermatology 1994;1994:12-12.
FULL TEXT  

Dermatology
Dover and Arndt
JAMA 1990;263:2633-2635.
ABSTRACT